Skip Navigation

Diversion Quarterly, Q2 2023

Diversion Quarterly, Q2 2023

The diversion market is consolidating and Bluesight is excited to welcome Medacist customers to our Community. Bluesight now provides drug diversion software to over 1600 hospitals. Starting in Q4, Bluesight will incorporate data from ControlCheck, RX Auditor, and RX Investigate to provide you with industry leading data on drug diversion trends.

Download the latest information about our suite of medication intelligence products by using the button below.

Want to read the rest?